Delivery Order SPE2DB24D9238-SPE2DB25FDRBN
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,189.60 by the Defense Logistics Agency on September 2, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a potential value of $499,999,999 and remains valid through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Xolair 150 mg/mL syringes. The contract is valued at $4,642.20 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025. This award carries no set-aside designation, allowing the vendor to compete directly in the federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Xolair 150 mg/ml syringes. The contract, valued at $1,547.40, operates under a firm fixed-price structure with an ultimate completion date of September 30, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $6,963.30 by the Defense Logistics Agency (DLA) for Xolair 150 mg/ml syringes. The award, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,547.40 by the Defense Logistics Agency for Xolair 150 mg/mL syringes. The contract, which carries a firm fixed-price structure with an ultimate completion date of September 26, 2025, was issued without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,321.10 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Xolair 150 mg/ml syringes. The contract, awarded without set-aside designation, carries a firm fixed-price structure with an ultimate completion date of September 18, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of October 3, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,284.40 on July 21, 2025, for Xolair 150 mg/ml syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and carries no set-aside designation. The product will be delivered to Park Ridge, Illinois, and is funded through the Medical Supply Chain division of the Defense Logistics...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $22,325.76 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml syringes and is expected to be completed by September 15, 2025. This delivery order was issued without a set-aside designation, demonstrating the company's competitive standing in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,642.20 by the Defense Logistics Agency (DLA) on September 4, 2025. The delivery order is for Xolair 150 mg/ml syringes, with an ultimate completion date of September 25, 2025. This award carries no set-aside designation, allowing the vendor to compete on equal footing in the federal procurement marketplace. The place of...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRBNDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,568.80 by the Defense Logistics Agency on September 16, 2025, for the supply of Xolair 150 mg/ml syringes. The contract contains no set-aside designation and is scheduled for completion by October 7, 2025, with performance occurring in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 single-award contract that remains valid through November 2026. The SPE2DB contract vehicle enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts to deliver branded and generic prescription drugs, biologics, and specialty medications to military health facilities. The Xolair delivery under this award represents one of numerous pharmaceutical product deliveries the company provides to support federal healthcare operations and military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 9/16/25 |